EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learning

Ailin Zhao, Xu Sun, Weishi Cheng, Yuqi Yang, Bing Xiang, Ting Niu

The Oncologist · 04.04.2025 · 30 (4)

DOI: 10.1093/oncolo/oyae221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, online erschienen am 12.04.2025. Verfasst von Ailin Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Hodgkin Disease, Machine Learning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Postdoctoral Fellowship Program, Post-Doctor Research Project, West China Hospital, Sichuan University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Composite lymphoma (CL) is rare. We conducted an analysis of 53 329 cases of diffuse large B-cell lymphoma (DLBCL), 17,916 cases of Hodgkin lymphoma (HL), and 869 cases of composite HL and DLBCL from the SEER database diagnosed between 2000 and 2019. Incidence rates showed increasing trends with age for CL and DLBCL, while HL exhibited 2 peak incidence rates: 42.05 (95% CI: 40.88-43.25) per million for the age group 20-24 and 43.20 (95% CI: 41.13-45.35) per million for 75-79. Higher incidence rates were observed in males (CL, 0.68, 95% CI: 0.62-0.74; HL, 29.65, 95% CI: 29.27-30.03; DLBCL, 86.18, 95% CI: 85.51-86.86) compared to females (CL, 0.40, 95% CI: 0.36-0.45; HL, 23.15, 95% CI: 22.83-23.49; DLBCL, 57.56, 95% CI: 57.06-58.06; P < .001). We first identified independent prognostic factors for composite HL and DLBCL, which were used for development of a scoring nomogram. Factors such as primary tumor site, marital status, chemotherapy, and sex predominantly influence short-term survival, while Ann Arbor stage plays a significant role in long-term survival. Furthermore, there were notable differences in demographic characteristics, survival outcomes, and death cause among CL, HL, and DLBCL. This study provides the first comprehensive report of composite HL and DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Large B-Cell, DiffuseHodgkin DiseaseMachine LearningHumansMaleFemaleMiddle AgedAdultAgedYoung AdultSEER ProgramAdolescentIncidencePrognosisAged, 80 and overChild

Stichwörter der Autor:innen

Hodgkin lymphomaSEER databasecomposite lymphomaddiffuse large cell B-cell lymphomamachine learning

Autor:innen und Institutionen

  • Department of Hematology, West China Hospital, Sichuan University, 610041, Chengdu, Sichuan, China.
  • Peking Union Medical College, Chinese Academy of Medical Sciences, 100730, Beijing, China.
  • West School of Medicine, Sichuan University, 610041, Chengdu, Sichuan, China.

Förderung

  • Postdoctoral Fellowship Program
  • Post-Doctor Research Project, West China Hospital, Sichuan University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province
  • Key Research, Development Program of Sichuan Province

Zitieren

APA

Zhao, A., Sun, X., Cheng, W., Yang, Y., Xiang, B., & Niu, T. (2025). Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learning. The Oncologist, 30(4). https://doi.org/10.1093/oncolo/oyae221

Vancouver

Zhao A, Sun X, Cheng W, Yang Y, Xiang B, Niu T. Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learning. The Oncologist. 2025;30(4). doi:10.1093/oncolo/oyae221

BibTeX
@article{Zhao2025,
  author = {Zhao, Ailin and Sun, Xu and Cheng, Weishi and Yang, Yuqi and Xiang, Bing and Niu, Ting},
  title = {Epidemiology characteristics and clinical outcomes of composite Hodgkin lymphoma and diffuse large B-cell lymphoma using machine learning},
  journal = {The Oncologist},
  year = {2025},
  volume = {30},
  number = {4},
  doi = {10.1093/oncolo/oyae221}
}
Kostenlos starten →